Scott Bendix, MD
Vascular Surgery · Farmington Hills, MINPI 1114288206
Payments from drug & device makers
What this record shows
This record is dominated by grants: $12,250 of the $20,299 with a category attached, or 60.3%. Medtronic accounts for 67.7% of it on its own, with 36 other manufacturers making up the rest. Reporting peaked in 2019 at $13,076 and has fallen 93.5% since, to $844 in 2025.
Across 150 payments — averaging $135.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$14K
- Endologix LLC$2K
- Terumo Medical Corporation$575
- W. L. Gore & Associates, Inc.$564
- Inari Medical, Inc.$458
- Lemaitre Vascular, Inc.$402
- plus $3K from 31 others
What the payments were for
- Grants$12,25060%
- Food & beverage$7,80838%
- Education$2411%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 21 | $13,741 |
| Endologix LLC | 11 | $2,006 |
| Terumo Medical Corporation | 10 | $575 |
| W. L. Gore & Associates, Inc. | 6 | $564 |
| Inari Medical, Inc. | 11 | $458 |
| Lemaitre Vascular, Inc. | 4 | $402 |
| Bard Peripheral Vascular, Inc. | 14 | $329 |
| Bolton Medical Inc | 5 | $325 |
| Acera Surgical, Inc. | 4 | $250 |
| Getinge USA Sales, LLC | 3 | $151 |
| Kerecis Limited | 6 | $141 |
| Boston Scientific | 4 | $138 |
| Access Pro Medical, LLC | 1 | $129 |
| Cook Medical LLC | 5 | $122 |
| Stryker | 4 | $100 |
| Johnson & Johnson | 4 | $90 |
| Imperative Care, Inc | 2 | $80 |
| Smith+Nephew | 3 | $70 |
| Tactile Systems Technology Inc | 3 | $65 |
| Convatec Inc. | 3 | $62 |
| Mozarc Medical US LLC | 2 | $58 |
| Cordis US CORP. | 3 | $52 |
| Shockwave Medical, Inc | 2 | $47 |
| Mimedx Group, Inc. | 2 | $37 |
| Integra Lifesciences Corporation | 2 | $36 |
| Surmodics, Inc. | 1 | $34 |
| Baxter Healthcare | 1 | $30 |
| Cardiva Medical, Inc. | 2 | $28 |
| Abbott | 1 | $25 |
| My01 Inc. | 1 | $23 |
| Laminate Medical Technologies Inc. | 1 | $23 |
| Braintree Laboratories, Inc. | 1 | $20 |
| Cashflow Solutions, LLC | 3 | $20 |
| Aroa Biosurgery Incorporated | 1 | $19 |
| Organogenesis Inc. | 1 | $18 |
| Teleflex LLC | 1 | $16 |
| Silk Road Medical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Endurant$12,884
- Alto Abdominal Stent Graft System$1,317
- FLOWTRIEVER CATHETER, S$434
- ENDURANT IIS$340
- AFX2 Bifurcated Endograft System$282
- Torus Stent Graft System$277
- ENDOCROSS Device$277
- Azur CX Detachable$268
- CT THROMBECTOMY SYSTEM KIT$230
- RESTOREFLOW$211
- Restrata Wound Matrix$148
- METACROSS OTW$133
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$133
- GORE ACUSEAL Vascular Graft$131
- Matriderm$129
- Relay Grafts$123
- FLIXENE$114
- GORE TAG Thoracic Branch Endoprosthesis$112
- Grafts$105
- ARTEGRAFT VASCULAR GRAFT$101
How this compares
$20,299 in reported general payments places this provider in the 85th percentile of 183 vascular surgery providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 21 | $25,564 |
| EliquisApixaban | 14 | $13,934 |
| Atorvastatin Calcium | 49 | $626 |
| ClopidogrelClopidogrel Bisulfate | 33 | $585 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $68 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $90 | $25,56421 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 183 vascular surgery providers in Michigan.
Other vascular surgery in Farmington Hills
- Ahmed GhamraouiFarmington Hills$13K
- Nicolas MouawadWest Branch$1.7M
- Enrique Criado PallaresMidland$800K
- Jordan KnepperEast Lansing$336K
- Joseph CuppariClinton Township$98K
- Eanas YassaGrand Rapids$81K
- Abedelkarim AbushmaiesBattle Creek$75K
- Kevin OnofreyDetroit$65K
- Yevgeniy RitsDetroit$57K
- Ryan KimSaginaw$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.